Stay updated on SNDX-5613 with Chemo in AML Clinical Trial
Sign up to get notified when there's something new on the SNDX-5613 with Chemo in AML Clinical Trial page.

Latest updates to the SNDX-5613 with Chemo in AML Clinical Trial page
- Check5 days agoChange DetectedNew Study Status entries and Revision: v3.4.0 with No FEAR Act data have been added to the record history. The page now includes a Show glossary toggle and green/red color-coded highlights to distinguish additions and deletions.SummaryDifference1%

- Check13 days agoChange DetectedThe history now includes several new 'Study Status' entries documenting recent updates to the trial's recruitment and status from 2026-01-14 to 2026-01-20.SummaryDifference0.7%

- Check20 days agoChange DetectedA new Study Status entry was added on 2026-01-13, followed by a series of January 2026 version updates, culminating in Revision: v3.3.4.SummaryDifference1%

- Check27 days agoChange DetectedNew version entries were added showing updates to the Study Status in the trial history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check34 days agoChange DetectedNew Study Status entries have been added for 2025-12-30 and 2025-12-27. A deletion for 2025-11-21 was recorded, updating the record's version history.SummaryDifference0.2%

- Check41 days agoChange DetectedFooter and header updates show Revision: v3.3.3, and the HHS Vulnerability Disclosure link was removed (as well as the previous Revision: v3.3.2 entry). This is a minor site-wide change that does not affect the study record content, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to SNDX-5613 with Chemo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-5613 with Chemo in AML Clinical Trial page.